The diversity of Plasmodium falciparum isolates from asymptomatic and symptomatic school-age children in Kinshasa Province, Democratic Republic of Congo.
Democratic Republic of Congo
Genetic diversity
Multiplicity of infection
Plasmodium falciparum
School-age children
Journal
Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802
Informations de publication
Date de publication:
20 Mar 2023
20 Mar 2023
Historique:
received:
13
10
2022
accepted:
10
03
2023
entrez:
21
3
2023
pubmed:
22
3
2023
medline:
23
3
2023
Statut:
epublish
Résumé
Understanding Plasmodium falciparum population diversity and transmission dynamics provides information on the intensity of malaria transmission, which is needed for assessing malaria control interventions. This study aimed to determine P. falciparum allelic diversity and multiplicity of infection (MOI) among asymptomatic and symptomatic school-age children in Kinshasa Province, Democratic Republic of Congo (DRC). A total of 438 DNA samples (248 asymptomatic and 190 symptomatic) were characterized by nested PCR and genotyping the polymorphic regions of pfmsp1 block 2 and pfmsp2 block 3. Nine allele types were observed in pfmsp1 block2. The K1-type allele was predominant with 78% (229/293) prevalence, followed by the MAD20-type allele (52%, 152/293) and RO33-type allele (44%, 129/293). Twelve alleles were detected in pfmsp2, and the 3D7-type allele was the most frequent with 84% (256/304) prevalence, followed by the FC27-type allele (66%, 201/304). Polyclonal infections were detected in 63% (95% CI 56, 69) of the samples, and the MOI (SD) was 1.99 (0.97) in P. falciparum single-species infections. MOIs significantly increased in P. falciparum isolates from symptomatic parasite carriers compared with asymptomatic carriers (2.24 versus 1.69, adjusted b: 0.36, (95% CI 0.01, 0.72), p = 0.046) and parasitaemia > 10,000 parasites/µL compared to parasitaemia < 5000 parasites/µL (2.68 versus 1.63, adjusted b: 0.89, (95% CI 0.46, 1.25), p < 0.001). This survey showed low allelic diversity and MOI of P. falciparum, which reflects a moderate intensity of malaria transmission in the study areas. MOIs were more likely to be common in symptomatic infections and increased with the parasitaemia level. Further studies in different transmission zones are needed to understand the epidemiology and parasite complexity in the DRC.
Sections du résumé
BACKGROUND
BACKGROUND
Understanding Plasmodium falciparum population diversity and transmission dynamics provides information on the intensity of malaria transmission, which is needed for assessing malaria control interventions. This study aimed to determine P. falciparum allelic diversity and multiplicity of infection (MOI) among asymptomatic and symptomatic school-age children in Kinshasa Province, Democratic Republic of Congo (DRC).
METHODS
METHODS
A total of 438 DNA samples (248 asymptomatic and 190 symptomatic) were characterized by nested PCR and genotyping the polymorphic regions of pfmsp1 block 2 and pfmsp2 block 3.
RESULTS
RESULTS
Nine allele types were observed in pfmsp1 block2. The K1-type allele was predominant with 78% (229/293) prevalence, followed by the MAD20-type allele (52%, 152/293) and RO33-type allele (44%, 129/293). Twelve alleles were detected in pfmsp2, and the 3D7-type allele was the most frequent with 84% (256/304) prevalence, followed by the FC27-type allele (66%, 201/304). Polyclonal infections were detected in 63% (95% CI 56, 69) of the samples, and the MOI (SD) was 1.99 (0.97) in P. falciparum single-species infections. MOIs significantly increased in P. falciparum isolates from symptomatic parasite carriers compared with asymptomatic carriers (2.24 versus 1.69, adjusted b: 0.36, (95% CI 0.01, 0.72), p = 0.046) and parasitaemia > 10,000 parasites/µL compared to parasitaemia < 5000 parasites/µL (2.68 versus 1.63, adjusted b: 0.89, (95% CI 0.46, 1.25), p < 0.001).
CONCLUSION
CONCLUSIONS
This survey showed low allelic diversity and MOI of P. falciparum, which reflects a moderate intensity of malaria transmission in the study areas. MOIs were more likely to be common in symptomatic infections and increased with the parasitaemia level. Further studies in different transmission zones are needed to understand the epidemiology and parasite complexity in the DRC.
Identifiants
pubmed: 36941587
doi: 10.1186/s12936-023-04528-z
pii: 10.1186/s12936-023-04528-z
pmc: PMC10025789
doi:
Substances chimiques
Merozoite Surface Protein 1
0
Antigens, Protozoan
0
Protozoan Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
102Subventions
Organisme : the Joint Usage/Research Center on Tropical Disease, Institute of Tropical Medicine, Nagasaki University
ID : 2020-Ippan-23
Informations de copyright
© 2023. The Author(s).
Références
Malar J. 2016 Jan 13;15:27
pubmed: 26762532
Mol Biol Evol. 2000 Oct;17(10):1467-82
pubmed: 11018154
Malar J. 2016 May 10;15(1):267
pubmed: 27165412
Malar J. 2018 Nov 14;17(1):423
pubmed: 30428916
Malar J. 2014 Jan 23;13:26
pubmed: 24456636
Clin Microbiol Rev. 2007 Jan;20(1):188-204
pubmed: 17223628
Malar J. 2020 Mar 18;19(1):115
pubmed: 32188442
Trends Parasitol. 2017 Feb;33(2):128-140
pubmed: 27939610
BMC Infect Dis. 2015 Aug 05;15:309
pubmed: 26242307
Korean J Parasitol. 2015 Aug;53(4):413-9
pubmed: 26323839
Clin Infect Dis. 2013 Nov;57(10):1409-16
pubmed: 23983244
Int J Parasitol. 2017 Feb;47(2-3):77-85
pubmed: 27825828
Front Immunol. 2020 Jan 22;10:3072
pubmed: 32038623
Malar J. 2018 Oct 25;17(1):386
pubmed: 30359280
Parasite Epidemiol Control. 2020 Oct 22;11:e00188
pubmed: 33145445
Am J Trop Med Hyg. 1996 Jun;54(6):632-43
pubmed: 8686784
Parasitol Today. 1994 May;10(5):182-4
pubmed: 15275468
Malar J. 2008 Jan 23;7:17
pubmed: 18215251
Malar J. 2020 Jun 8;19(1):203
pubmed: 32513191
Trends Parasitol. 2016 Mar;32(3):187-196
pubmed: 26826784
Lancet Glob Health. 2020 Dec;8(12):e1499-e1511
pubmed: 33222799
Parasitol Today. 1997 Jul;13(7):262-7
pubmed: 15275063
Infect Genet Evol. 2006 Sep;6(5):417-24
pubmed: 16517218
Infect Immun. 2006 Feb;74(2):1313-22
pubmed: 16428781
Parasit Vectors. 2011 Dec 13;4:233
pubmed: 22166488
Malar J. 2016 Jul 11;15:353
pubmed: 27401016
Malar J. 2018 Apr 3;17(1):147
pubmed: 29615044
Curr Top Microbiol Immunol. 2005;295:83-104
pubmed: 16265888
Am J Trop Med Hyg. 2017 Sep;97(3):753-757
pubmed: 28990911
J Trop Med. 2020 Mar 19;2020:1386587
pubmed: 32308690
Malar J. 2021 Oct 2;20(1):389
pubmed: 34600558
Parasite Immunol. 2004 Jan;26(1):7-17
pubmed: 15198641
Sci Rep. 2019 Jun 21;9(1):9022
pubmed: 31227760
Malar J. 2009 Oct 30;8:250
pubmed: 19878560
Malar J. 2011 Sep 22;10:276
pubmed: 21936949
Am J Trop Med Hyg. 1997 Feb;56(2):141-7
pubmed: 9080871
PLoS One. 2016 Jun 09;11(6):e0157074
pubmed: 27280792
Malar J. 2012 Jul 03;11:223
pubmed: 22759447
Am J Trop Med Hyg. 1999 Jul;61(1 Suppl):36-43
pubmed: 10432043
Pan Afr Med J. 2019 Apr 12;32:183
pubmed: 31312296
Nature. 2017 Oct 26;550(7677):515-518
pubmed: 29019978
Bull World Health Organ. 1966;35(6):873-82
pubmed: 5298036
Parasitol Int. 2022 Aug;89:102590
pubmed: 35472441
Malar J. 2009 Jun 20;8:135
pubmed: 19545390
J Infect Dis. 2018 Jun 20;218(2):265-276
pubmed: 29554284
Lancet. 1997 Jun 7;349(9066):1650-4
pubmed: 9186382
Afr Health Sci. 2019 Sep;19(3):2446-2456
pubmed: 32127816
Malar J. 2019 Apr 11;18(1):130
pubmed: 30971231
Nature. 2015 Oct 8;526(7572):207-211
pubmed: 26375008
Malar J. 2011 Apr 06;10:79
pubmed: 21470428
Parasitol Res. 2022 Jan;121(1):167-175
pubmed: 34993632
PLoS One. 2014 Jul 02;9(7):e97899
pubmed: 24988302
Nat Med. 2000 Jun;6(6):689-92
pubmed: 10835687
Microbes Infect. 2009 Jan;11(1):108-14
pubmed: 19028595
Malar J. 2020 Nov 10;19(1):403
pubmed: 33172455
Pathog Glob Health. 2019 May;113(3):133-142
pubmed: 31144611
PLoS Med. 2017 Nov 30;14(11):e1002456
pubmed: 29190300
J Infect Dis. 2009 Apr 15;199(8):1151-4
pubmed: 19284307
Malar J. 2015 Feb 14;14:73
pubmed: 25889847
Malar J. 2018 Dec 7;17(1):458
pubmed: 30526609
Parasit Vectors. 2018 May 30;11(1):323
pubmed: 29843783
PLoS One. 2011;6(10):e26616
pubmed: 22073118
Am J Trop Med Hyg. 2015 Sep;93(3 Suppl):79-86
pubmed: 26259945
PLoS One. 2015 Jul 24;10(7):e0134061
pubmed: 26207758
Insects. 2016 Oct 03;7(4):
pubmed: 27706105
Malar J. 2018 Feb 20;17(1):83
pubmed: 29458365
Immunol Today. 1991 Mar;12(3):A68-71
pubmed: 2069680
Trop Med Int Health. 2014 Nov;19(11):1294-309
pubmed: 25145389
J Parasitol Res. 2016;2016:3074803
pubmed: 27110390
Exp Parasitol. 2007 Jan;115(1):32-40
pubmed: 16797008
Gene. 2007 Aug 1;397(1-2):153-60
pubmed: 17574779
Infect Genet Evol. 2021 Dec;96:105143
pubmed: 34800712
Ann Trop Med Parasitol. 1983 Aug;77(4):355-77
pubmed: 6357121
Malar J. 2013 May 01;12:147
pubmed: 23634705
Mol Ecol. 2013 Jan;22(2):273-85
pubmed: 23121253
Acta Trop. 2018 Jul;183:78-83
pubmed: 29626433
Mem Inst Oswaldo Cruz. 1992;87 Suppl 3:37-42
pubmed: 1343716
Acta Trop. 2018 Feb;178:27-33
pubmed: 28993182
Bull Soc Pathol Exot. 2001 Jul;94(2 Pt 2):195-8
pubmed: 16579077
Malar J. 2016 Jul 08;15:350
pubmed: 27392905
Trans R Soc Trop Med Hyg. 1999 Jul-Aug;93(4):369-74
pubmed: 10674079